drugset / Trial / NCT00417794
Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD
Phase 1
Completed
38 enrolled
University of Oklahoma
Eli Lilly and Company · collabMark L. Wolraich, M.D. · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to determine if atomoxetine hydrochloride improves inattention, hyperactivity, and impulsivity problems in children exposed to alcohol during birth.
Timeline
- Start
- 2005-08
- Primary completion
- 2015-04-22
- Completion
- 2015-04-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atomoxetine | Other / unclassified | 1.4 mg/kg | — |